So many applications for the defensin mimetic platform. The gonnhorea bacterium is, I believe, Gram negative. One of the other compounds in development may possibly be effective. Whether Brilacidin itself is effective, it's hard to say. Maybe, but also a good idea to manage expectations in my opinion.

Speaking of which, it would be nice to get an update on where we are with some of the pre-clinical research on other compounds in the DM platform. We'll be due for a shareholders meeting soon, won't we?